FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

735230005: Durvalumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3513725013 Durvalumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3513726014 Durvalumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Durvalumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Durvalumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing durvalumab Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier 1
Product containing durvalumab in parenteral dose form (medicinal product form) Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier 1
Durvalumab Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier 1
Product containing only durvalumab in parenteral dose form (medicinal product form) Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier 1
Durvalumab 500mg/10ml solution for infusion vials Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 500mg/10ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials 1 vial Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Durvalumab 500mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 500mg/10ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) 1 vial Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) 1 vial Has specific active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Durvalumab 500mg/10ml solution for infusion vials Has active ingredient False Durvalumab Inferred relationship Existential restriction modifier
Durvalumab 120mg/2.4ml solution for infusion vials Has active ingredient False Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 500mg/10ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier
Imfinzi 120mg/2.4ml concentrate for solution for infusion vials (AstraZeneca UK Ltd) Has active ingredient True Durvalumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start